Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The company's antibody-drug conjugate and bispecific antibody pipeline includes peptide-linker components, and its oncology focus positions it strongly in the Oncology Peptide Therapy segment (11.79% CAGR through 2031)
More common with intramuscular administration than subcutaneous
Its targeted mechanism makes it relevant in studies focused on weight management and metabolic health
Check if the correct dosage is still in the syringe after removing air bubbles
US$ 23.91
US$ 21.67
US$ 21.53
